Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7418 p325
16 September 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Pharmacy representation on PECs must not be lost

It is essential that clinical pharmacy leaders are part of reconfigured primary care trust professional executive committees (PECs), say PEC pharmacists following an announcement that the committees are here to stay but their form and responsibilities may change.

Duncan Selbie, commissioning director at the Department of Health, wrote to strategic health authority chief executives last week to set out the department’s plans for the future of PECs, whose roles, membership and functions are to be reviewed. In the letter, he argues that the current role of PECs is too vague. “As a result some PECs have developed to suit the needs of their local PCT, but others have withered,” he wrote.
Other reasons cited for the review include current legislation making it difficult for PCTs to evolve and the introduction of practice-based commissioning having implications for clinical leadership, governance and accountability. “SHA and PCT reconfigurations are further drivers for a review of the role of the PEC against these crucial changes,” he added.
The DoH plans to carry out a rapid review aimed at producing a document for consultation in mid-October. Following consultation, revised guidance will be issued early next year and new arrangements will probably come into effect from April 2007. Guidance on interim arrangements for PECs is provided in the letter.

Brian Jolley, a pharmacist and PEC chairman at Waveney PCT, Suffolk, said that it is essential that pharmacy engages and participates in both the interim and future PECs, to promote the profession and to ensure that it is included in the strategic thinking of reconfigured PCTs. “If national initiatives are to be carried down to a local level it is vital the there is pharmacy representation on the new PECs. It is also essential that PEC pharmacists link in with local pharmaceutical committees and pharmacists at a local level to make sure that these initiatives are realistic and appropriate,” he added.

John Carr, a pharmacist and PEC chairman at East Staffordshire PCT, commented: “Mr Selbie believes that the rise of practice-based commissioning will supplant PECs as the largest aspect of clinical leadership — I think he may need to validate this outside a small group of enthusiasts.”

He added that Mr Selbie should also be sure that practice-based commissioning takes place in a multidisciplinary environment where nurses, pharmacists, dentists, optometrists and allied health professionals can embrace the responsibilities of commissioning cost-effective health interventions, before burying the current PEC model.

He does, however, believe that a review of PECs is appropriate. “There are many models of success — the important feature is effective clinical leaders who have emerged from a variety of professions. I look for opportunities for pharmacists and other professions to be included where they are proven leaders, not just because they represent a profession,” he said.

Back to Top


©The Pharmaceutical Journal